News und Analysen
Hautkrebs bald besiegt? Round Table mit Europas Top-Forschern. Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 210% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bi
Hautkrebs bald besiegt? Round Table mit Europas Top-Forschern. 210% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX)
10.07.23 08:11
London (www.aktiencheck.de, Anzeige)
Cracks In The Labor Market? Not Yet, But They’re Coming
The June employment situation summary revealed weaker-than-expected job growth and a potential crack in the labor market. The news suggests weakening demand for employment and is backed up by
Who Wins And Who Loses With China's Metal Restrictions
It is no secret that the trade wars between the United States and China have only intensified over the past several months, with escalations being explicitly made on the chip and semiconductor
Fortinet Positioned For Growth In AI-Based Cybersecurity Boom
Cybersecurity is a hot item, as spending on enterprise information security is forecast to grow fast. One factor driving growth? You guessed it: AI.
Stocks like Palo Alto Networks Inc. (NASDAQ:
Three AI Trades That Could Double This Year
AI and, specifically, generative AI are the hottest topics this year. While big-name players like NVIDIA (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and Microsoft (NASDAQ: MSFT) will
Perion Network Is Monetizing The Internet And Delivering Value
Perion Network (NASDAQ: PERI) is emerging as a stand-alone play on digitization and a potential takeover target for more prominent players. It’s Wildfire platform and a suite of applications
Hautkrebs bald besiegt? Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 212% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 212% mit Biotech Ak
Hautkrebs bald besiegt? Erstkl. Studienergebnisse. Massives Kaufsignal. 212% Biotech Hot Stock nach 134.452% mit Biogen
07.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Could Meta Be Risking Another Sell Off With Its New "Threads"?
Mark Zuckerberg has started a battle on more than one front. He has chosen not only the company that has most effectively dominated short-form written content but also an adversary known to be a
2 Must-Have Specialized ETFs for the Long-Term Investor
Constructing a long-term investment portfolio can be a lot like building a house.
First, you pour in the foundation. These are the tried and true pillars that have been around for decades — and
Yield Curve Tests New Lows, Where Markets Are Seeking Safety
As markets come to a significant turning point, investors can benefit from understanding where money has been and where it may be going into, as pivots in the flow of investment preferences
$1 Billion Deal For Moderna To Expand Product Pipeline in China
The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in the money markets
Eilt: Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 217% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vida
Eilt: Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 217% Biotech Aktientip nach 15.973% mit BioNTech
06.07.23 08:02
London (www.aktiencheck.de , Anzeige)
Amazon Is Having Its Best Run In Years, But Should You Chase It?
With fellow tech heavyweights like Apple Inc (NASDAQ: AAPL), Meta Inc (NASDAQ: META), and Alphabet Inc (NASDAQ: GOOGL) all seeing strong rallies this year, it should be no surprise that Amazon Inc
3 (AI) Plays That Could Rocket Higher In Q3
AI spending is set to explode. The analysts can’t agree on the final figures but agree on one thing: the numbers will be huge. One industry, the grocery industry, if you can believe it, is
EV Makers Deliver Big...What it Means for Their Stocks
Global vehicle electrification is going full speed ahead.
A fleet of electric vehicle (EV) manufacturers provided monthly and quarterly updates over the weekend that can be summed up in one word
Goldman Sachs Reportedly Mulling Apple Card Move To Amex
The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
- Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, Swissmedic, and the Therapeutic Goods
Moderna kündigt weltweite Zulassungsanträge für seinen Impfstoff MRNA-1345 gegen das Respiratorische Synzytial-Virus (RSV) an
- Moderna hat Zulassungsanträge für den RSV-Prüfimpfstoff mRNA-1345 bei der Europäischen Arzneimittelagentur, bei Swissmedic und bei der Therapeutic Goods Administration in
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 134.452% mit Biogen
05.07.23 08:17
London (www.aktiencheck.de, Anzeige)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 31.205% mit Amgen ($AMGN)
04.07.23
London (www.aktiencheck.de, Anzeige)
Tesla Production Cranks Into High Gear, Shares Follow
Tesla (NASDAQ: TSLA) was expected to increase production and set a record, but the Q2 results were shocking. The company produced 479,700 vehicles in the quarter and delivered 466,140 compared to
Krebs bald besiegt? Sensationelle Studienergebnisse. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 224% mit Biotech Aktientip Vidac Pharma
Krebs bald besiegt? Sensationelle Studienergebnisse. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX)
03.07.23 08:17
London (www.aktiencheck.de , Anzeige)
Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine
The filing follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines
Pending approval, Moderna's updated COVID-19 vaccine
Moderna reicht Zulassungsantrag für seinen neu angepassten COVID-19-Impfstoff bei der Europäischen Arzneimittelagentur ein
Die Einreichung folgt auf die Empfehlung der Regulierungsbehörden und öffentlichen Gesundheitseinrichtungen auf internationaler Ebene hinsichtlich der Entwicklung von monovalenten
Tesla: Can Downgrades Make Sense After A 170% Rally?
Sometimes the stock market can really make you scratch your head. As investors, we’re used to being always told to follow a trend, buy into a good thing, don’t catch the falling knife. This is why